| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $4.1M | -22.9% |
| SG&A Expense | $4.5M | -17.8% |
| Operating Income | -$8.7M | +20.3% |
| Income Tax | $0 | — |
| Net Income | -$120K | +98.9% |
| EPS (Basic) | -$0.53 | +97.4% |
| EPS (Diluted) | -$0.53 | +97.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.0M | +128.3% |
| Current Assets | $12.1M | +124.4% |
| Total Assets | $12.2M | +121.9% |
| Current Liabilities | $5.6M | +25.0% |
| Total Liabilities | $5.6M | +25.0% |
| Stockholders' Equity | $6.6M | +531.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.3M | +35.1% |
| Financing Cash Flow | $14.0M | -7.7% |